Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
Open Access
- 1 January 2011
- journal article
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 7 (4), 215-222
- https://doi.org/10.3988/jcn.2011.7.4.215
Abstract
Park MJ, et al. J Clin Neurol. 2011 Dec;7(4):215-222. http://dx.doi.org/10.3988/jcn.2011.7.4.215Keywords
This publication has 45 references indexed in Scilit:
- Dopamine-Induced Conformational Changes in Alpha-SynucleinPLOS ONE, 2009
- Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cellsNeuroscience Letters, 2009
- Metal binding to alpha-synuclein peptides and its contribution to toxicityBiochemical and Biophysical Research Communications, 2009
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?Neuroscience Letters, 2009
- Clustering of α-Synuclein on Supported Lipid Bilayers: Role of Anionic Lipid, Protein, and Divalent Ion ConcentrationBiophysical Journal, 2009
- Controlling the mass action of α‐synuclein in Parkinson’s diseaseJournal of Neurochemistry, 2008
- Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s diseaseBiochemical and Biophysical Research Communications, 2006
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic MembranesJournal of Biological Chemistry, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997